These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 7622098)

  • 1. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
    Pfisterer J; Kommoss F; Sauerbrei W; Rendl I; Kiechle M; Kleine W; Pfleiderer A
    Gynecol Oncol; 1995 Aug; 58(2):149-56. PubMed ID: 7622098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA ploidy is an independent prognostic indicator of overall survival in stage I endometrial endometrioid carcinoma.
    Santala M; Talvensaari-Mattila A
    Anticancer Res; 2003; 23(6D):5191-6. PubMed ID: 14981988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study.
    Friberg LG; Norén H; Delle U
    Gynecol Oncol; 1994 Apr; 53(1):64-9. PubMed ID: 8175025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-risk endometrial carcinoma: assessment of a treatment policy based on tumor ploidy and identification of additional prognostic indicators.
    Lim P; Aquino-Parsons CF; Wong F; Dupuis B; Phillips D; Zhou C; Gilks CB
    Gynecol Oncol; 1999 May; 73(2):191-5. PubMed ID: 10329033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
    Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
    J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma.
    Silverman MB; Roche PC; Kho RM; Keeney GL; Li H; Podratz KC
    Gynecol Oncol; 2000 Apr; 77(1):1-7. PubMed ID: 10739683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ploidy status: its impact on early-stage endometrial adenocarcinoma.
    Goodman A; Bell DA; Rice LW
    Gynecol Oncol; 1993 Dec; 51(3):355-61. PubMed ID: 8112645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.
    Nordström B; Strang P; Bergström R; Nilsson S; Tribukait B
    Cancer; 1996 Nov; 78(9):1942-51. PubMed ID: 8909315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma.
    Russo A; Bazan V; Migliavacca M; Zanna I; Tubiolo C; Tumminello FM; Dardanoni G; Cajozzo M; Bazan P; Modica G; Latteri M; Tomasino RM; Colucci G; Gebbia N; Leto G
    Clin Cancer Res; 2000 Jan; 6(1):178-84. PubMed ID: 10656448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
    Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
    Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study.
    Strang P; Stenkvist B; Bergström R; Stendahl U; Valdes del Campo M; Tribukait B
    Anticancer Res; 1991; 11(2):783-8. PubMed ID: 2064334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
    Salvesen HB; Iversen OE; Akslen LA
    Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of cell kinetics in endometrial adenocarcinoma.
    Mariani L; Conti L; Antenucci A; Vercillo M; Atlante M; Gandolfo GM
    Anticancer Res; 2000; 20(5B):3569-74. PubMed ID: 11131664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of DNA content and S-phase fraction in epithelial ovarian carcinomas analyzed by image cytometry.
    Reles AE; Gee C; Schellschmidt I; Schmider A; Unger M; Friedmann W; Lichtenegger W; Press MF
    Gynecol Oncol; 1998 Oct; 71(1):3-13. PubMed ID: 9784312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.